The role of vascular endothelial growth factor (VEGF) in oral dysplasia and oral squamous cell carcinoma

Oral Oncology

Volumn 42, Issue 4, 2006, Pages 337-342

  Johnstone, Shane ^a   Logan, Richard M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Oral cancer; Oral dysplasia; Oral squamous cell carcinoma; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL PROLIFERATION; DISEASE COURSE; DYSPLASIA; GENE EXPRESSION; HUMAN; METASTASIS; MOUTH; MOUTH CANCER; PRIORITY JOURNAL; REVIEW;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; MOUTH NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PRECANCEROUS CONDITIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645052215     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.06.020     Document Type: Review

References (48)

1. S.R. Moore, N.W. Johnson, A.M. Pierce, and D.F. Wilson The epidemiology of tongue cancer: a review of global incidence Oral Dis 6 2 2000 75 84
2. P.B. Sugerman, and N.W. Savage Current concepts in oral cancer Aust Dent J 44 3 1999 147 156
3. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1 1990 4 6
4. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 6 2003 669 676
5. M. Macluskey, L.M. Chandrachud, S. Pazouki, M. Green, D.M. Chisholm, and G.R. Ogden Apoptosis, proliferation, and angiogenesis in oral tissues possible relevance to tumour progression J Pathol 191 4 2000 368 375
6. J. Carlile, K. Harada, R. Baillie, M. Macluskey, D.M. Chisholm, and G.R. Ogden Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation J Oral Pathol Med 30 8 2001 449 457
7. S. Pazouki, D.M. Chisholm, M.M. Adi, G. Carmichael, M. Farquharson, and G.R. Ogden The association between tumour progression and vascularity in the oral mucosa J Pathol 183 1 1997 39 43
8. C.N. Penfold, M. Partridge, R. Rojas, and J.D. Langdon The role of angiogenesis in the spread of oral squamous cell carcinoma Br J Oral Maxillofac Surg 34 1 1996 37 41
9. C. Ruhrberg Growing and shaping the vascular tree: multiple roles for VEGF Bioessays 25 11 2003 1052 1060
10. M.J. Cross, and L. Claesson-Welsh FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition Trends Pharmacol Sci 22 4 2001 201 207
11. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr Rev 18 1 1997 4 25
12. M.J. Cross, J. Dixelius, T. Matsumoto, and L. Claesson-Welsh VEGF-receptor signal transduction Trends Biochem Sci 28 9 2003 488 494
13. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors Faseb J 13 1 1999 9 22
14. G. Neufeld, O. Kessler, and Y. Herzog The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF Adv Exp Med Biol 515 2002 81 90
15. J. Grunstein, J.J. Masbad, R. Hickey, F. Giordano, and R.S. Johnson Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature Mol Cell Biol 20 19 2000 7282 7291
16. G.H. Fong, L. Zhang, D.M. Bryce, and J. Peng Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice Development 126 13 1999 3015 3025
17. H. Gitay-Goren, S. Soker, I. Vlodavsky, and G. Neufeld The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules J Biol Chem 267 9 1992 6093 6098
18. N.S. Levy, S. Chung, H. Furneaux, and A.P. Levy Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR J Biol Chem 273 11 1998 6417 6423
19. J. Rak, Y. Mitsuhashi, L. Bayko, J. Filmus, S. Shirasawa, and T. Sasazuki Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis Cancer Res 55 20 1995 4575 4580
20. M. Detmar, L.F. Brown, K.P. Claffey, K.T. Yeo, O. Kocher, and R.W. Jackman Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis J Exp Med 180 3 1994 1141 1146
21. M. Detmar Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis J Invest Dermatol 122 1 2004 xiv xv
22. L.F. Brown, T.J. Harrist, K.T. Yeo, M. Stahle-Backdahl, R.W. Jackman, and B. Berse Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme J Invest Dermatol 104 5 1995 744 749
23. P. Carmeliet Angiogenesis in health and disease Nat Med 9 6 2003 653 660
24. P. Auguste, S. Lemiere, F. Larrieu-Lahargue, and A. Bikfalvi Molecular mechanisms of tumor vascularization Crit Rev Oncol Hematol 54 1 2005 53 61
25. J.C. Yang Bevacizumab for patients with metastatic renal cancer: an update Clin Cancer Res 10 18 Pt 2 2004 6367S 6370S
26. F. Kabbinavar, H.I. Hurwitz, L. Fehrenbacher, N.J. Meropol, W.F. Novotny, and G. Lieberman Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 21 1 2003 60 65
27. J. Folkman Angiogenesis-dependent diseases Semin Oncol 28 6 2001 536 542
28. J. Folkman, K. Watson, D. Ingber, and D. Hanahan Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 6219 1989 58 61
29. N. Weidner, J.P. Semple, W.R. Welch, and J. Folkman Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1 1991 1 8
30. M.K. Brawer, R.E. Deering, M. Brown, S.D. Preston, and S.A. Bigler Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity Cancer 73 3 1994 678 687
31. P.M. Speight, and P.R. Morgan The natural history and pathology of oral cancer and precancer Commun Dent Health 10 Suppl 1 1993 31 41
32. G.L. Tipoe, Y. Jin, and F.H. White The relationship between vascularity and cell proliferation in human normal and pathological lesions of the oral cheek epithelium Eur J Cancer B Oral Oncol 32B 1 1996 24 31
33. J.J. Homer, J. Greenman, and N.D. Stafford Angiogenesis in head and neck squamous cell carcinoma Clin Otolaryngol 25 3 2000 169 180
34. K. Tae, A.K. El-Naggar, E. Yoo, L. Feng, J.J. Lee, and W.K. Hong Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis Clin Cancer Res 6 7 2000 2821 2828
35. M. Moriyama, S. Kumagai, S. Kawashiri, K. Kojima, K. Kakihara, and E. Yamamoto Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma Oral Oncol 33 5 1997 369 374
36. Y.K. Wong, C.J. Liu, P.C. Kwan, and S.Y. Chao Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma J Oral Maxillofac Surg 61 11 2003 1257 1262
37. Y.J. Chen, Y.T. Jin, D.B. Shieh, S.T. Tsai, and L.W. Wu Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells Oral Oncol 38 7 2002 699 705
38. S. Shintani, C. Li, T. Ishikawa, M. Mihara, K. Nakashiro, and H. Hamakawa Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma Oral Oncol 40 1 2004 13 20
39. Z.J. Shang, and J.R. Li Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression J Oral Pathol Med 34 3 2005 134 139
40. B.C. Denhart, A.J. Guidi, K. Tognazzi, H.F. Dvorak, and L.F. Brown Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia Lab Invest 77 6 1997 659 664
41. T. Maeda, S. Matsumura, H. Hiranuma, A. Jikko, S. Furukawa, and T. Ishida Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: its association with tumour progression and p53 gene status J Clin Pathol 51 10 1998 771 775
42. B.D. Smith, G.L. Smith, D. Carter, C.T. Sasaki, and B.G. Haffty Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma J Clin Oncol 18 10 2000 2046 2052
43. R. Schimming, P. Reusch, J. Kuschnierz, and R. Schmelzeisen Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance? J Craniomaxillofac Surg 32 3 2004 176 181
44. M. Uehara, K. Sano, H. Ikeda, J. Sekine, A. Irie, and T. Yokota Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma Oral Oncol 40 3 2004 321 325
45. L.L. Gleich, P.W. Biddinger, F.D. Duperier, and J.L. Gluckman Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation Head Neck 19 4 1997 276 280
46. E. Jablonska, L. Piotrowski, J. Jablonski, and Z. Grabowska VEGF in the culture of PMN and the serum in oral cavity cancer patients Oral Oncol 38 6 2002 605 609
47. Z.J. Shang, J.R. Li, and Z.B. Li Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma Int J Oral Maxillofac Surg 31 5 2002 495 498
48. B.D. Smith, G.L. Smith, D. Carter, M.P. DiGiovanna, K.M. Kasowitz, and C.T. Sasaki Molecular marker expression in oral and oropharyngeal squamous cell carcinoma Arch Otolaryngol Head Neck Surg 127 7 2001 780 785